Vora Corporate Finance
  • Home
  • Who We Are
    • Our Values
    • Our Team
    • Careers
  • What We Do
    • Debt Syndication
    • Private Equity & IPO
    • Merger & Acquisitions
    • Registered Valuers
      • Rating Advisory
      • Valuation Advisory
  • Insights
  • Media
    • Capital Market Updates
  • Contact
Select Page
IPO: Gland Pharma IPO subscribed 2.05 times

IPO: Gland Pharma IPO subscribed 2.05 times

by Vora Corporate Finance | Jan 18, 2021 | Insights, Private Equity & IPO

Hyderabad based Gland Pharma Ltd. is an injectable-focused company with a footprint in 60 countries. Company mainly operates in complex injectable under B2B model. The issue price of the stock was kept Rs. 1490 to Rs. 1500 per share at P/E of around 30. IPO was...
IPO: Equitas Small Finance Bank IPO listed at discount

IPO: Equitas Small Finance Bank IPO listed at discount

by Vora Corporate Finance | Jan 18, 2021 | Insights, Private Equity & IPO

Equitas Small Finance Bank is a small finance bank founded in 2007 as a microfinance lender, with headquarters in Chennai, India. It began banking in September 2016 after receiving RBI approval. The Issue price of IPO was Rs.33 at P/E ratio of around 13.5. Stock was...
Stock Markets Update November 2020

Stock Markets Update November 2020

by Vora Corporate Finance | Jan 16, 2021 | Insights, Registered Valuers

BSE Sensex went up by 11.45% in November 2020 to close at 44,150. Nifty 50 closed at 12,969 in November, higher by 11.40% from 39,614 in October closing. Expectation of quick arrival of Covid-19 vaccines, slowing of Covid19 infections, abundant liquidity, economic...
PE: Reliance Retail raises funds by diluting 10%

PE: Reliance Retail raises funds by diluting 10%

by Vora Corporate Finance | Jan 16, 2021 | Insights, Private Equity & IPO, Registered Valuers

Reliance Retail Ventures Limited (RRVL) completes fund raise Rs. 47,265 Crore for 10.09% stake in the company. RRVL replicated the speed with which it raised funds for JIO platform earlier in the year. Reliance Retail Ventures Limited is a subsidiary of Reliance...
PE: Biocon Biologics raises Rs.1125 Crore from Goldman Sachs

PE: Biocon Biologics raises Rs.1125 Crore from Goldman Sachs

by Vora Corporate Finance | Jan 16, 2021 | Insights, Private Equity & IPO

Biocon Ltd., a bio-pharmaceutical company, announced that the Board of its subsidiary Biocon Biologics Ltd (Biocon Biologics) has approved a Rs.1,125 Crore (approx. USD 150 million) fund raise from Goldman Sachs. As per the proposed terms, Goldman Sachs will be issued...
« Older Entries

Recent Posts

  • IPO: Gland Pharma IPO subscribed 2.05 times
  • IPO: Equitas Small Finance Bank IPO listed at discount
  • Stock Markets Update November 2020
  • PE: Reliance Retail raises funds by diluting 10%
  • PE: Biocon Biologics raises Rs.1125 Crore from Goldman Sachs

Categories

  • Capital Market Updates
  • Credit Rating Advisory
  • Debt Syndication
  • Insights
  • Merger & Acquisitions
  • Private Equity & IPO
  • Registered Valuers
  • Registered Valuers

Who We Are

  • Our Values
  • Our Team
  • Careers

What We Do

  • Debt Syndication
  • Private Equity & IPO
  • Merger & Acquisitions
  • Registered Valuers

Who We Are

  • Our Values
  • Our Team
  • Careers

Contact Us

Vora Management Consulting Pvt. Ltd.
Vora Institute, Opp Sam's Pizza, Near Swatik Cross Roads, Off CG Road, Navrangpura, Ahmedabad, Gujarat 380009

contact@vorafin.com
karanpvora@gmail.com
+91 98240 29939
Vora Corporate Finance
  • Facebook
  • Twitter
  • Twitter

© 2020 Vora Management Consulting Pvt. Ltd.